Skip to main content
. 2022 Jul 13;59(10):5970–5986. doi: 10.1007/s12035-022-02932-1

Fig. 3.

Fig. 3

Acute/long-term changes in brain post-MHV-1 coronavirus infection. A Normal brain cortex. B Representative image from MHV-1-infected mouse brain cortex showed “perivascular cavitation, congested blood vessel, pericellular halos, darkly stained nuclei, vacuolation of neuropil, pyknotic nuclei and acute eosinophilic necrosis at 7 days (acute phase)” [1]. C MHV-1-infected mouse brain cortex (12 months post-infection). F–I Enlarged images of C showed widespread neuronal necrosis (long arrows), pyknotic nuclei/neuronal clearing (short arrows), vacuolation of neuropil (arrowhead), congested blood vessels (blue arrows), perivascular cavitation (yellow arrows, Virchow–robin space), darkly stained nuclei (green arrow), neuronophagia (red arrow, presence of necrotic neurons surrounded by invaded hypertrophic microglia (I). D and E Treatment of MHV-1-infected mice with the peptide drug SPIKENET (5 mg/kg) ameliorated the above-mentioned changes at day 7 and 12 months post-infection, respectively. These findings suggest that the changes observed in the brain post-long-term infection are more severe than in the acute phase and the peptide SPIKENET has therapeutic potential in reducing MHV-1 infection (n = 3). (H&E, original magnification 400 × (A–E), and F–I are enlarged images of C)